急诊就诊时无发热的脓毒症患者与抗生素治疗延迟相关
该回顾性多中心观察性研究纳入三家转诊医院共4293例脓毒症患者,按初始体温分为无发热组(<37.3 °C)和发热组(≥37.3 °C)。结果显示无发热组28天死亡的调整OR为1.76(95%CI 1.46-2.12),完成Hour-1集束化治疗记录亚组中调整OR为1.68(95%CI 1.34-2.11)。无发热组1小时内接受抗生素的比例为15.6%(323/2076),低于发热组的18.3%(395/2156)(p=0.02),且接受抗生素时间更长(209.3±277.9 vs 175.5±207.9,p<0.01)。作者认为需改进对无发热脓毒症患者的早期识别与治疗策略。
要点
- 无发热脓毒症患者28天死亡调整OR为1.76(95%CI 1.46-2.12),高于发热患者。
- 完成Hour-1集束化治疗记录的亚组中,无发热患者28天死亡调整OR为1.68(95%CI 1.34-2.11)。
- 无发热组1小时内接受抗生素比例为15.6%(323/2076),低于发热组的18.3%(395/2156)(p=0.02)。
- 无发热组接受抗生素时间较发热组长(209.3±277.9 vs 175.5±207.9,p<0.01)。
- 28天存活者初始体温高于死亡者(37.5 °C±1.2 °C vs 37.1 °C±1.2 °C,p<0.01)。
适用人群与场景
- 三家转诊医院的脓毒症患者,2014年5月至2016年2月按SEPSIS-2标准纳入,2016年3月至2020年4月按SEPSIS-3标准纳入。
- 按初始体温分为无发热组(<37.3 °C)和发热组(≥37.3 °C)。
诊断标准与关键阈值
- 体温分组阈值:无发热定义为<37.3 °C,发热定义为≥37.3 °C。
- 脓毒症诊断标准:2014年5月至2016年2月采用SEPSIS-2标准,2016年3月至2020年4月采用SEPSIS-3标准。
研究设计与关键结果
- 研究类型:回顾性多中心观察性研究,纳入三家转诊医院共4293例脓毒症患者。
- 28天存活者初始体温显著高于28天死亡者(37.5 °C±1.2 °C vs 37.1 °C±1.2 °C,p<0.01)。
- 多因素logistic回归显示无发热脓毒症患者28天死亡的调整OR为1.76(95%CI 1.46-2.12)。
- 完成Hour-1集束化治疗记录的患者亚组中,无发热患者28天死亡调整OR为1.68(95%CI 1.34-2.11)。
- 实施Hour-1集束化治疗后,无发热组1小时内接受抗生素比例为15.6%(323/2076),发热组为18.3%(395/2156)(p=0.02)。
- 发热组接受抗生素速度快于无发热组(175.5±207.9 vs 209.3±277.9,p<0.01)。
证据类型、等级与局限
- 证据类型:回顾性多中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,无发热脓毒症患者28天死亡风险更高且接受抗生素延迟,需改进对无发热脓毒症患者的早期识别与治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether there is a difference in antibiotic administration time and prognosis in afebrile sepsis patients compared to febrile sepsis patients.
METHODS: This was retrospective multicenter observational study. Data collected from three referral hospitals. Data were collected from May 2014 through February 2016 under the SEPSIS-2 criteria and from March 2016 to April 2020 under the newly released SEPSIS-3 criteria. Patients were divided into two groups based on body temperature: afebrile (<37.3 °C) and febrile (≥37.3 °C). The relationship between initial body temperature and 28-day mortality were analyzed using multivariable logistic regression. The subgroup analysis was conducted on patients with complete Hour-1 bundle performance records.
RESULTS: We included 4293 patients in this study. Initial body temperatures in 28-day survivors were significantly higher than in 28-day non-survivors (37.5 °C ± 1.2 °C versus 37.1 °C ± 1.2 °C, p < 0.01). Multivariable logistic regression analysis was performed in afebrile and febrile sepsis patients. Adjusted odds ratio of afebrile sepsis patients for 28-day mortality was 1.76 (95% Confidence interval 1.46-2.12). As a result of performing the Hour-1 bundle, the number of patients who received antibiotics within 1 h was smaller in the afebrile sepsis patients (323/2076, 15.6%) than in the febrile sepsis patients (395/2156, 18.3%) (p = 0.02). In the subgroup analysis of patients with complete Hour-1 bundle performance records adjusted odds ratio of afebrile sepsis patients for 28-day mortality was 1.68 (95% Confidence interval 1.34-2.11). The febrile sepsis patients received antibiotics faster than the afebrile sepsis patients (175.5 ± 207.9 versus 209.3 ± 277.9, p < 0.01).
CONCLUSIONS: Afebrile sepsis patients were associated with higher 28-day mortality compared to their febrile counterparts and were delayed in receiving antibiotics. This underscores the need for improved early detection and treatment strategies for the afebrile sepsis patients.
参考来源
- Kwak H, Kwon WY, Jo YH, et al. Afebrile status at the time of emergency department visit is associated with delayed antibiotic therapy in patients with sepsis (revised). Am J Emerg Med. 2024. PMID: 38976929. doi:10.1016/j.ajem.2024.06.031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。